PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97302049 |
Filing Date: 03/08/2022 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\973\020\97302049\xml1 \ FTK0002.JPG |
*SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | NKT |
*COLOR MARK | NO |
*COLOR(S) CLAIMED (If applicable) |
|
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the letters NKT in stylized text above an arc design. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 480 x 280 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | NiKang Therapeutics, Inc. |
*MAILING ADDRESS | 200 Powder Mill Road, Bldg E500 |
*CITY | Wilmington |
*STATE (Required for U.S. applicants) |
Delaware |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
19803 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Anti-cancer preparations; Pharmaceutical preparations for the treatment of cancer |
*FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
ATTORNEY INFORMATION | |
NAME | Philip R. Zender |
ATTORNEY DOCKET NUMBER | 119005.tbd |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Squire Patton Boggs (US) LLP |
STREET | 275 Battery Street, Suite 2600 |
CITY | San Francisco |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 94111 |
PHONE | 415-954-0200 |
FAX | 415-393-9887 |
EMAIL ADDRESS | ip-squiretm@squirepb.com |
OTHER APPOINTED ATTORNEY | Caroline H. Mead, Joseph P. Grasser, Raisa Dyadkina, Ivan Rothman |
CORRESPONDENCE INFORMATION | |
NAME | Philip R. Zender |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ip-squiretm@squirepb.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Rekha Bansal/ |
* SIGNATORY'S NAME | Rekha Bansal |
* SIGNATORY'S POSITION | VP of Intellectual Property |
SIGNATORY'S PHONE NUMBER | 4082188467 |
* DATE SIGNED | 03/08/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97302049 |
Filing Date: 03/08/2022 |
The applicant's current Correspondence Information: |
Philip R. Zender |
PRIMARY EMAIL FOR CORRESPONDENCE: ip-squiretm@squirepb.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|